Search results
29 maj 2024 · Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to: Treat osteoporosis in postmenopausal women at high risk for fracture. Increase bone mass in men with osteoporosis at high risk for fracture.
Prolia is an injection given every 6 months to treat osteoporosis in men, postmenopausal women, and people who take corticosteroid medicines who are at high risk for fractures.
11 lis 2021 · Denosumab 60 mg administered as a subcutaneous injection every 6 months (Q6M) prevents osteoclast-mediated bone resorption (i.e., bone loss), reducing the risk of osteoporotic fracture.
Denosumab (also known as Prolia®) is a drug treatment for osteoporosis. It can help to strengthen bones, making them less likely to break. It is given as an injection every six months. Denosumab isn’t usually given as a first treatment for osteoporosis.
Prolia is a prescription injection that helps strengthen and protect your bones from fracture. Learn about its benefits, side effects, safety information, and how to start the conversation with your doctor.
30 cze 2023 · Prolia (denosumab) is a prescription drug that’s used to treat osteoporosis and bone loss. Prolia comes as a liquid solution that’s given as an injection under the skin.
Prolia® injection is a brand of denosumab, which treats osteoporosis. Osteoporosis is a condition that weakens your bones, making them more susceptible to fractures. Xgeva® is another brand of denosumab that treats high calcium levels caused by cancer and prevents bone breaks.
